P&G: Pantene athletes prove ‘Healthy is the New Beautiful’ at 2012 Olympic Games
LONDON — In honor of the London 2012 Olympic Games being the first in modern history in which women competed in as many sports as men, Procter & Gamble’s hair care brand Pantene celebrated the success of its 11 athlete beauty ambassadors —10 of whom competed in London — for their 12 medals and embodiment of Pantene motto “Healthy is the New Beautiful.”
From Saudi Arabia sending female athletes to the Olympic Games for the first time in the country’s history to the first time that U.S. female athletes outnumbered male, female athletes dominated the conversation during the 17-day competition. Pantene sponsored 10 of these elite London competitors as beauty ambassadors, including the U.S.’s Natalie Coughlin, Argentina’s Gisela Dulko and Great Britain’s Victoria Pendleton.
“The London 2012 Olympic Games were a milestone for women in sports: every country’s delegation included at least one female athlete and every sport included both male and female competitions,” explained Kathryn Olson, CEO of the U.S.-based Women’s Sports Foundation, which focuses on advancing the lives of girls and women through sports and physical activity. “Pantene’s prominent support for women’s sports throughout the competition has greatly helped raise visibility for the strength, talent, and beauty female athletes possess. Pantene and its beauty ambassadors are also helping to raise awareness for the relationship between sports and health, revealing the beauty of strong female athletes in a context that’s encouraging to young girls who need good role models in sports and in life.”
In London, the Pantene beauty ambassadors won more than 12 medals in six sports, including four gold. Russia’s gymnast Evgeniya Kanaeva won a gold medal. China’s diver Wu Minxia mounted the podium winning a gold medal. Great Britain’s cyclist Victoria Pendleton topped the competition at her final Olympic Games with one gold and one silver medal. The group also was featured in Pantene’s first truly global marketing campaign to support the Olympic Games, which featured new packaging and a fully integrated marketing campaign that lived across multiple channels.
“We truly believe that healthy is the new beautiful and this was showcased through our engagement with athletes and consumers around the world during London 2012,” stated Hanneke Faber, VP and brand franchise leader of global hair care at P&G. “We have seen tremendous continued support of this concept since its launch earlier this year. Our Olympians were able to see firsthand how Pantene’s performance allowed them to concentrate on their athletic performance and how the product stands up to the rigors of competing in the Olympics. We provided these women and the more than 10,000 London athletes and their families with healthy, beautiful hair through our salons at the P&G Family Home and in the Athlete Village. We are so proud of our Pantene athlete ambassadors, whose gold medal count of four placed them in the same company of the top 20 countries that participated in the Olympic Games.”
With the London 2012 Olympic Games being considered the first truly “social games,” Pantene’s online engagement resulted in connections to more than 1.5 million people over the last month to showcase the brand’s “Healthy is the New Beautiful” message.
The Pantene campaign leading up to and during London 2012 was part of P&G’s Worldwide Olympic Partner status, which was anchored by the "Thank You, Mom" campaign for the London 2012 Olympic Games. P&G’s “Thank you, Mom” campaign helped improve life for moms around the world and provided support for the moms of the Pantene athletes and the moms of thousands of other Olympians. Looking to the Sochi 2014 Olympic Winter Games, the brand will continue its support of athletes.
Novartis drug appears effective in liver transplant patients
EAST HANOVER, N.J. — An experimental drug therapy under development by Novartis for liver transplant patients appears to provide similar efficacy and better kidney function, compared with a drug made by Astellas Pharma, according to results of a late-stage clinical trial.
A phase-3 study published in the American Journal of Transplantation found that patients taking RAD001 (everolimus) with a reduced dose of Astellas’ Prograf (tacrolimus) experienced equal efficacy and superior kidney function to patients taking Prograf alone.
Novartis markets everolimus for various cancers and for kidney transplant patients under the trade names Afinitor and Zortress, respectively. The drug has not received Food and Drug Administration approval for liver transplant patients, which is why Novartis is using the code name RAD001 for the study, the company said.
FDA approves Genentech’s Lucentis for diabetic macular edema
SILVER SPRING, Md. — Regulators have approved a biotech drug made by Genentech for treating a complication related to diabetes.
The Food and Drug Administration approved Lucentis (ranibizumab) for diabetic macular edema, a cause of vision loss in people with diabetes. The drug already was approved for age-related macular degeneration.
"Diabetes is a major public health issue in our country, and all patients with diabetes are at risk of developing diabetic macular edema," FDA Division of Transplant and Ophthalmology Products director Renata Albrecht said. "Today’s approval represents a major development for the treatment of people whose vision is impaired by DME as a complication of their disease."
According to the Centers for Disease Control and Prevention, Type 1 and Type 2 diabetes affect about 26 million people in the United States and are the leading cause of blindness among people ages 20 to 74 years. In 2010, 3.9 million adult diabetics reported vision problems. DME happens when fluid leaks into the macula, the central part of the retina where sharp, straightforward vision occurs.